Associated Papers
Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers.
Bensenane R et al.
Cancers, 2024
Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario.
de Freitas Ribeiro AA et al.
European Journal of Medical Research, 2024
Genotype-phenotype pattern analysis of pathogenic PAX9 variants in Chinese Han families with non-syndromic oligodontia.
Ren J et al.
Frontiers in Genetics, 2023
37056289 (PubMed )
Supplement: Table1.XLSX › Sheet1
Breast Cancer-Related Low Penetrance Genes.
Kang D et al.
Advances in Experimental Medicine and Biology, 2021
Minigene Splicing Assays Identify 12 Spliceogenic Variants of BRCA2 Exons 14 and 15.
Fraile-Bethencourt E et al.
Frontiers in Genetics, 2019
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.
Ellingson MS et al.
Breast Cancer Research and Treatment, 2015
Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.
Davis MY et al.
Journal of the Neurological Sciences, 2013
ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.
Stankovic T et al.
American Journal of Human Genetics, 1998
Select a paper to view details